Clinical News
Informatics
Industry News
Medical, Legal, And Practice
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Genitourinary Radiology: Page 6
CLS begins evaluation of new thermal therapy system
By
AuntMinnieEurope.com staff writers
Image-guided focal laser ablation technology developer Clinical Laserthermia Systems (CLS) said that its new Transberg thermal therapy system is now being evaluated for use in MRI/ultrasound fusion-guided focal laser ablation of prostate tumors.
October 26, 2021
Lucida launches validation study for AI software
By
AuntMinnieEurope.com staff writers
Researchers from U.K. artificial intelligence (AI) software developer Lucida Medical and Hampshire Hospitals NHS Foundation Trust have launched a retrospective cohort validation study of the firm's Pi AI-based software for prostate cancer detection on MRI.
September 6, 2021
Can AI help to improve radiologist accuracy in prostate MRI?
By
Erik L. Ridley
An artificial intelligence (AI)-based computer-aided detection software application can improve the performance of radiologists in reading biparametric prostate MRI exams, according to Swiss-led research.
August 31, 2021
When is the best time to stop following low-risk prostate cancer?
By
AuntMinnieEurope.com staff writers
There are a variety of factors associated with the discontinuation of active surveillance of men with low-risk prostate cancer, both demographic and clinical, according to a study published August 20 in the
Journal of Urology
.
August 29, 2021
When is the best time to stop following low-risk prostate cancer?
By
AuntMinnieEurope.com staff writers
There are a variety of factors associated with the discontinuation of active surveillance of men with low-risk prostate cancer, both demographic and clinical, according to a study published August 20 in the
Journal of Urology
.
August 22, 2021
Karolinska team seeks to optimize prostate cancer screening
By
Kate Madden Yee
Scientists from the Karolinska Institute in Stockholm have used a new type of blood test to screen for prostate cancer to reduce unnecessary MRI scans by 36% and avoid overdiagnosis. Their study was posted on 12 August in
Lancet Oncology
.
August 15, 2021
MRI for prostate cancer screening reduces unnecessary biopsies
By
Kate Madden Yee
Swedish researchers have found that using MRI for prostate cancer screening finds clinically significant cancer and reduces unnecessary biopsies, according to a study published on 9 July in the
New England Journal of Medicine
.
July 18, 2021
Swedish MRI study adds momentum to prostate cancer screening
By
Kate Madden Yee
A group from the Karolinska in Stockholm has reported that using MRI for prostate cancer screening finds clinically significant cancer and reduces unnecessary biopsies. The team published its results on 9 July in the
New England Journal of Medicine
.
July 13, 2021
AI can enhance identification of kidney stones on CT scans
By
Erik L. Ridley
Investigators from the University of Turgut Ozal in Malatya, Turkey, have developed an artificial intelligence (AI) algorithm to detect and localize kidney stones on noncontrast CT exams. The algorithm yielded 96.8% accuracy in testing and was deemed to be ready for clinical use.
June 22, 2021
Groups launch registry to promote SPECT for prostate cancer
By
AuntMinnieEurope.com staff writers
The Oncidium Foundation and Telix Pharmaceuticals have launched a registry to promote the use of SPECT with a prostate-specific membrane antigen agent for prostate cancer detection.
April 20, 2021
Quantib secures CE Mark for prostate MRI software
By
AuntMinnieEurope.com staff writers
Artificial intelligence (AI) software developer Quantib has secured the CE Mark for its Quantib Prostate package for prostate MRI interpretation.
April 8, 2021
Early prostate MRI scans can help reduce mortality rates
By
Kate Madden Yee
Researchers from University College London have reported that performing MRI scans before biopsy on men with high prostate-specific antigen scores could cut prostate cancer death rates by as much as 18% versus no screening, while also minimizing the harms of screening.
March 14, 2021
Previous Page
Page 6 of 22
Next Page